human chorionic gonadotrophin
PreclinicalSmall molecule
human chorionic gonadotrophin is one of 10 small molecule programs targeting Endometrial. It is currently in Preclinical.
2
Indications
7
Total Trials
1
Active Trials
9
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
6 competitors in Endometrial
#DrugCompanyPhaseTrials
1Cataflam
NovartisPreclinical
Orgalutran
OOrganon and Co
Preclinical
human chorionic gonadotrophin
TThe Egyptian IVF-ET Center
Preclinical
Methoxyflurane - Penthrox
UUniversity of Manitoba
Preclinical
Specific Treatment
AAssistance Publique - Hôpitaux de Paris
Preclinical
Human Menopausal Gonadotrophin
RReproductive & Genetic Hospital of CITIC-Xiangya
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Embryo Transfer2 trials
In Vitro Fertilization (IVF)1 trial
Poor Ovarian Stimulation Response in In Vitro Fertilization (IVF) Program
Completed·—·Phase 1·NCT02640976·216 enrolled
1 more indication
Unspecified1 trial
Human Chorionic Gonadotrophin & Trigger
Unknown status·—·Phase 3·NCT02264847·200 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- TThe Egyptian IVF-ET Center